Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2021-04-15 | 2021-04-21 | 137547 |
| ACT PIOGLITAZONE | 15MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137882 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-04-21 | 2021-07-29 | 137885 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2021-04-21 | 2021-05-20 | 137890 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-04-21 | 2021-06-03 | 137896 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137899 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137902 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
| TEVA-VALSARTAN | 160MG | TABLET | Resolved | 2021-04-22 | 2023-06-09 | 137936 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
| TEVA-LENOLTEC NO. 2 | 15MG 15MG 300MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138285 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-04-29 | 2021-08-07 | 138291 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2021-04-29 | 2021-09-02 | 138297 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
| TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138303 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-04-29 | 2024-04-01 | 138306 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138309 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
| TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
| ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
| ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
| ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
| ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |